4
LIFE SCIENCES OTC transformational redesign delivers positive ROI of €1.8 million in profit and €3.5 million in cash flow for biopharmaceutical major About the client Major biopharmaceutical company Industry Life Sciences Business need addressed Understand, define, and manage an effective and efficient Order to Cash (OTC) process in support of the function becoming a value-add business partner for the organization. Genpact solution End-to-end OTC process redesign to drive greater transparency, smarter processes, and more effective business strategies. Business impact • Increased profit by €1.8 million annually through improved recovery of invalid deductions and disputes • 11% savings from improved cash flow and 6% efficiency savings • Improved cycle time for query resolution • Improved controllership and data quality built into ERP • Enhanced controllership of cash received Business challenge This major biopharmaceutical company sells products to third-party customers such as wholesalers, private and public hospitals, pharmacies, and other pharma manufacturing companies mainly located in Eastern Europe, based on royalties, and delivers export orders to its international clients. The client utilized different distribution models across the different countries: Pull Strategy: Actual customer orders specifically requested from client’s manufacturing units Push Strategy: Third-Party Logistics (3PL) ownership model: Products manufactured and sent to 3PLs based on historical sales and forecast Push Strategy: Client ownership model: Products manufactured and sent to 3PLs without change in ownership. Invoicing and collections responsibility lay with the client, but activity was managed by the 3PL These models were implemented using fragmented systems, tools, and structures. The overall organization was decentralized, with local accountability down to the functional level and no end-to-end visibility into the OTC process. In addition, the European OTC processes for third-party customers did not consistently include or apply critical best practices across different entities. A further lack of analytics resulted in undefined business strategies, while manual processing created long turnaround times. In a conscious move toward becoming a more intelligent enterprise, a global biopharmaceutical company wanted an end-to-end Order to Cash (OTC) assessment of its European export entities and U.S. operations to help the OTC process become a value-add business partner within the company. In a competitive bid process, they chose Genpact’s proven Smart Enterprise Process (SEP SM ) methodology for its logical, holistic approach and process-level granularity. A six-week end-to-end assessment provided transparency into the entire OTC function and resulted in €1.8 million increased profit annually and €3.5 million additional cash flow impact for our client.

Genpact's Life Consulting Services helps deliver positive ROI of €1.8 million in profit and €3.5 million in cashflow for biopharmaceutical major

Embed Size (px)

DESCRIPTION

In the midst of a momentous industry evolution, life sciences companies must adapt their business operations to remain competitive.With roughly a dozen of the top 25 global life sciences companies as clients, Genpact helps pharmaceuticals and medical devices companies evolve their operations through advanced operating models that leverage technology and analytics to enable smart processes. We call the result Genpact Intelligent OperationsSM

Citation preview

  • L I F E S C I E N C E S

    OTC transformational redesign delivers positive ROI of 1.8 million in profit and 3.5 million in cash flow for biopharmaceutical major

    About the clientMajor biopharmaceutical company

    IndustryLife Sciences

    Business need addressedUnderstand, define, and manage an

    effective and efficient Order to Cash

    (OTC) process in support of the function

    becoming a value-add business partner

    for the organization.

    Genpact solutionEnd-to-end OTC process redesign to drive

    greater transparency, smarter processes,

    and more effective business strategies.

    Business impact Increasedprofitby1.8millionannually

    through improved recovery of invalid

    deductions and disputes

    11%savingsfromimprovedcashflow

    and6%efficiencysavings

    Improvedcycletimeforquery

    resolution

    Improvedcontrollershipanddata

    qualitybuiltintoERP

    Enhancedcontrollershipofcash

    received

    Business challengeThis major biopharmaceutical company sells products to third-party

    customerssuchaswholesalers,privateandpublichospitals,pharmacies,

    and other pharma manufacturing companies mainly located in Eastern

    Europe, based on royalties, and delivers export orders to its international

    clients. The client utilized different distribution models across the different

    countries:

    PullStrategy:Actualcustomerordersspecificallyrequestedfromclients

    manufacturing units

    PushStrategy:Third-PartyLogistics(3PL)ownershipmodel:Products

    manufacturedandsentto3PLsbasedonhistoricalsalesandforecast

    PushStrategy:Clientownershipmodel:Productsmanufacturedand

    sentto3PLswithoutchangeinownership.Invoicingandcollections

    responsibilitylaywiththeclient,butactivitywasmanagedbythe3PL

    Thesemodelswereimplementedusingfragmentedsystems,tools,

    andstructures.Theoverallorganizationwasdecentralized,withlocal

    accountabilitydowntothefunctionallevelandnoend-to-endvisibility

    into the OTC process.

    Inaddition,theEuropeanOTCprocessesforthird-partycustomersdidnot

    consistently include or apply critical best practices across different entities.

    Afurtherlackofanalyticsresultedinundefinedbusinessstrategies,while

    manual processing created long turnaround times.

    Inaconsciousmovetowardbecomingamoreintelligententerprise,a

    globalbiopharmaceuticalcompanywantedanend-to-endOrdertoCash

    (OTC) assessment of its European export entities and U.S. operations to

    helptheOTCprocessbecomeavalue-addbusinesspartnerwithinthe

    company.Inacompetitivebidprocess,theychoseGenpactsprovenSmart

    EnterpriseProcess(SEPSM) methodology for its logical, holistic approach

    andprocess-levelgranularity.Asix-weekend-to-endassessmentprovided

    transparencyintotheentireOTCfunctionandresultedin1.8million

    increasedprofitannuallyand3.5millionadditionalcashflowimpactfor

    our client.

  • IntheU.S.,processeswerehighlyautomated,butgapsinmaster

    data creation and dispute management threatened customer

    satisfaction, compliance, and cash and cost optimization.

    Althoughtheclientembracedend-to-endbusinessprocess

    management, they needed to better understand their OTC

    functioninordertosupportFinancesglobalcontributiontothe

    enterprisesgoals.Theclientsoverallobjectivewastodeliver

    tangible,sustainablebenefitstotheenterpriseonkeybusiness

    outcomessuchascashflow,customersatisfaction,profit,and

    compliance.

    Genpact approachGenpactsgoalistohelpourclientsbecomemoreinnovative,

    better able to adapt to challenges, and more globally

    effectivewhatwecallanintelligententerprise.Forthis

    client,weusedourSEPSMframeworktoconductathorough

    analysis of their OTC operations and create an overall

    improvement roadmap. We used this granular methodology to

    thoroughly diagnose the end-to-end OTC process and identify

    opportunities for improvement such as:

    Processesweredecentralizedandtherewasalackof

    enablingtechnologiessuchasworkflow

    Therewasnovisibilityintokeymetricsincashapplication,

    such as unapplied cash and payment optimization

    Keymetricstomanageandmeasurebacklogsincontracts

    werenotimplemented

    SAPfeaturesthatcouldhavedrivenmoreprocessefficiency

    werenotfullyimplemented

    This successful European assessment convinced the client

    ofGenpactscapabilities.TheclientthenrequestedaU.S.

    assessmenttounderstandimprovementopportunitieswithinits

    GrosstoNetaccrualandprocessingactivities.

    Genpact recommendation

    Genpactpresenteddetailedprocessandtechnology

    recommendations that formed a comprehensive OTC

    transformationroadmap,alongwithadetailedpriortizationand

    implementation plan:

    RecommendedatemplatefortheOTCcycletoimprove

    keymetricssuchasDaysSalesOutstanding(DSO),dilution,

    compliance, and customer satisfaction

    Designedacentralized,standardized,andautomatedprocess

    across export businesses instead of the current five entities

    managedinfivedifferentways

    Implementedmetricsforperformancebenchmarkingand

    managementacrossOTC,includingbacklogmetricsfor

    contractsandnewmetricsforSAP/BusinessIntelligence

    Conducted statistical modeling on multiple linear regression

    variablesin8-10majorrevenuedebittypestoreduce

    variation and true-up adjustments

    Increasedvisibilityintounappliedcashandpaymentmethod

    optimization

    ImplementedSAPusageenhancementsforbetterorder

    management, billing, cash application, claims management,

    and dispute resolution processes

    Genpactsholisticstrategyforaddressingprocessgapsand

    improving end-to-end performance resulted in a phased

    implementation of the recommendations based on priority for all

    businessunitsacrossthisclientsU.S.andEuropeanexportbusiness.

    3.5 million

    Cash flow improvement

    Profit impact Net incremental cost

    Operational efficiency

    Overall impact

    **Payback = 5 months

    3.5 million in WC 1.8 million in profit**

    1.8 million

    700K

    200K

    1. Compliance 2. Customer satisfaction

    Export business U.S. business

    Order to Cash transformational redesign

    3. Cash & cost optimization

  • Business impactTheclientsgoalofmakingOTCavaluedriverfortheenterprise

    iswellunderway.BenefitsderivedfromthedualEuropeanand

    U.S. assessments thus far include:

    Increasedannualprofitof1.8million

    Cashflowimpactof3.5million

    11%savingsfromimprovedcashflow

    6%efficiencysavings

    Bettercontrollershipandvisibility

    Genpactpowersamoreintelligententerprisethroughprocess.

    Our combination of smart analytics, processes, and technologies

    helps our clients become not just more efficient but also

    more effective in serving customers, driving higher customer

    satisfaction,andgrowth.

  • About Genpact

    GenpactLimited(NYSE:G)isagloballeaderintransformingandrunningbusinessprocessesandoperations.Wehelpclientsbecomemorecompetitivebymakingtheirenterprisesmoreintelligent:moreadaptive,innovative,globallyeffectiveandconnected.GenpactstandsforGeneratingImpactforhundredsofclientsincludingover100oftheFortuneGlobal500.Weofferanunbiasedcombinationofsmarterprocesses,analyticsandtechnologythroughour60,000+employeesin24countries,withkeymanagementbasedinNewYorkCity.BehindGenpactspassionforprocessandoperationalexcellenceistheLeanandSixSigmaheritageofaformerGeneralElectricdivisionthathasservedGEbusinessesfor15+years.

    For more information, visit www.genpact.com.FollowGenpactonTwitter, Facebook and LinkedIn.

    2013CopyrightGenpact.AllRightsReserved.

    For More Information, Contact:

    Sajeesh KumarAssistantVicePresident,OTCPracticeIndia:[email protected]

    Julia PshenichnayaAssistantVicePresident,Sales&OperationsUS:[email protected]

    Twitter,